Highlights
About
Mutation-resistant Viral Defense Technologies
AVA Bio Defender is a biotechnology company specializing in the development of mutation-resistant viral defense with heritable genetic resistance in animals and drug design for human therapy.
Using siRNA technology, the company has developed a highly efficient and sophisticated gene-delivery system that is designed to deliver antiviral protection for all body cells, currently for use in poultry. The company also uses CRISPR technology in animals, which allows directed editing of target genomes.
For humans, AVA Bio Defender develops molecules that can be used as medicine to treat infected people, regardless of the virus’ mutations.
The company’s technologies provide the ability to create resistance to the future mutations of an existing virus, making animals inherently resistant and enabling the development of highly effective medicines for humans.
Identity
| Name | AVA Bio Defender |
|---|---|
| Slug | ava-bio-defender |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwNWsnI4KDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Hillel Street 4, Jerusalem, Israel |
Web & social
| Website | https://ava-biod.com/cgi-sys/suspendedpage.cgi |
|---|---|
| https://www.linkedin.com/company/66267434 |
Classifications
Funding
| Total raised | $2.5M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}